BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.66% |
| 2 | Healthcare | 6.66% |
| 3 | Financials | 5.71% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Communication Services | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Capital City Bank Group
CCBG
$898M
| $83.8K | ﹤0.01% |
4,165
+876
| +27% | +$23K |
|
|
BCEL
3152
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $83K | ﹤0.01% |
5,018
+4,261
| +563% | +$77.3K |
|
|
ODT
3153
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $83K | ﹤0.01% |
3,006
+1,299
| +76% | +$37.9K |
|
|
KE
3154
Kimball Electronics
KE
$626M
| $82.9K | ﹤0.01% |
7,593
+1,742
| +30% | +$26K |
|
3155
Ducommun
DCO
$3.01B
| $82.5K | ﹤0.01% |
3,319
+803
| +32% | +$30.9K |
|
3156
PUT
Occidental Petroleum
OXY
$57.7B
| $82.2K | ﹤0.01% |
71
-2,426
| -97% | -$79.7K |
|
3157
Carriage Services
CSV
$555M
| $82.2K | ﹤0.01% |
5,090
+1,051
| +26% | +$22.7K |
|
3158
PUT
Norwegian Cruise Line
NCLH
$8.98B
| $82.2K | ﹤0.01% |
75
| – | – |
|
|
PFNX
3159
DELISTED
Pfenex Inc.
PFNX
| $82K | ﹤0.01% |
9,292
+4,816
| +108% | +$52.9K |
|
|
MDP
3160
DELISTED
Meredith Corporation
MDP
| $81.9K | ﹤0.01% |
6,701
-4,035
| -38% | -$107K |
|
|
MTEM
3161
DELISTED
Molecular Templates, Inc.
MTEM
| $81.8K | ﹤0.01% |
410
+208
| +103% | +$45.5K |
|
3162
Bar Harbor Bankshares
BHB
$681M
| $81.7K | ﹤0.01% |
4,727
+992
| +27% | +$21.1K |
|
3163
Team
TISI
$101M
| $81.7K | ﹤0.01% |
1,257
+141
| +13% | +$17.5K |
|
3164
West Bancorporation
WTBA
$511M
| $81.5K | ﹤0.01% |
4,982
+1,444
| +41% | +$31.2K |
|
3165
SIGA Technologies
SIGA
$207M
| $81K | ﹤0.01% |
16,952
+10,607
| +167% | +$51.6K |
|
3166
Sportsman's Warehouse
SPWH
$46.8M
| $81K | ﹤0.01% |
13,153
+2,307
| +21% | +$14.4K |
|
3167
Farmers & Merchants Bancorp
FMAO
$486M
| $80.8K | ﹤0.01% |
3,118
+708
| +29% | +$19.4K |
|
3168
Rigel Pharmaceuticals
RIGL
$762M
| $80.7K | ﹤0.01% |
5,172
+3,239
| +168% | +$68.9K |
|
|
TSC
3169
DELISTED
TriState Capital Holdings, Inc.
TSC
| $80.4K | ﹤0.01% |
8,318
+5,451
| +190% | +$109K |
|
3170
Greif Class B
GEF.B
$4.22B
| $80.3K | ﹤0.01% |
2,005
+403
| +25% | +$18.1K |
|
|
APLT
3171
DELISTED
Applied Therapeutics
APLT
| $80.3K | ﹤0.01% |
2,455
+1,345
| +121% | +$54.4K |
|
3172
Equity Bancshares
EQBK
$1.07B
| $80.2K | ﹤0.01% |
4,649
+2,886
| +164% | +$72.7K |
|
|
ACBI
3173
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $79.9K | ﹤0.01% |
6,735
+4,176
| +163% | +$70.2K |
|
3174
UFP Technologies
UFPT
$2.48B
| $79.7K | ﹤0.01% |
2,092
+536
| +34% | +$24.6K |
|
|
AMNB
3175
DELISTED
American National Bankshares Inc
AMNB
| $79.5K | ﹤0.01% |
3,325
+736
| +28% | +$23.9K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.